Frequency of human papillumavirus among women with high-grade squamous intraepithelial lesions and invasive cervical cancer attending shahid beheshti university of medical sciences clinics, Tehran, Iran

Iranian Journal of Public Health

Volumn 43, Issue 11, 2014, Pages 1563-1568

  Khodakarami, Nahid ^a   Moradi, Afshin ^b   Mirzaei, Hamidreza ^b   Farzaneh, Farah ^c   Yavari, Parvin ^a   Akbari, Mohamad Esmaeil ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Human papillomavirus; Invasive cervical cancer; Iran; Squamous intraepithelial lesions

Indexed keywords

EID: 84911486902     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Bray F, Ren JS, Masuyer E, Ferlay J (2013). Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer, 132:1133-45.
2. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F (2013). Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer, 49:1374-403.
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127:2893-917.
4. Ministry of Health (2009-2010) Iran Cancer Registration Report 2008-2009. In: Iran Center for Disease Control & Prevention pp. 434.
5. Nokiani FA, Akbari H, Rezaei M, Madani H, Ale Agha ME (2008). Cost--effectiveness of pap smear in Kermanshah, Iran. Asian Pac J Cancer Prev, 9:107-10.
6. Maryam Afrakhteh, Nahid Khodakarami, Afshin Moradi, Ehsan Alavi, Farshad Hosseini Shirazi F(2007). A study of 13315 Papanicolau Smear Diagnoses in Shohada Hospital. Journal of Family and Reproductive Health, 1, (2), 75-79.
7. Khodakarami N, Clifford GM, Yavari P et al. (2012). Human papillomavirus infection in women with and without cervical cancer in Tehran, Iran. Int J Cancer, 131:E156-61.
8. Khodakarami N, Farzaneh F, Aslani F, Alizadeh K (2011). Comparison of Pap smear, visual inspection with acetic acid, and digital cervicography as cervical screening strategies. Arch Gynecol Obstet, 284:1247-52.
9. Castle PE, Sideri M, Jeronimo J, Solomon D, Schiffman M (2008). Risk assessment to guide the prevention of cervical cancer. J Low Genit Tract Dis, 12:1-7.
10. Franceschi S, Plummer M, Clifford G, de Sanjose S, Bosch X, Herrero R, Munoz N, Vaccarella S, International Agency for Research on Cancer Multicentric Cervical Cancer Study G,International Agency for Research on Cancer Human Papillomavirus Prevalence Surveys Study G (2009). Differences in the risk of cervical cancer and human papillomavirus infection by education level. Br J Cancer, 101:865-70.
11. Vinodhini K, Shanmughapriya S, Das BC, Natarajaseenivasan K (2012). Prevalence and risk factors of HPV infection among women from various provinces of the world. Arch Gynecol Obstet, 285:771-7.
12. Kjaer SK, Munk C, Junge J, Iftner T (2014). Carcinogenic HPV prevalence and age-specific type distribution in 40,382 women with normal cervical cytology, ASCUS/LSIL, HSIL, or cervical cancer: what is the potential for prevention, Cancer Causes and Control, 25(2):179-89.
13. Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, Vignat J, Ferlay J, Bray F, Plummer M, Franceschi S (2012). Global burden of human papillomavirus and related diseases. Vaccine, 30 Suppl 5:F12-23.
14. Vaccarella S, Bruni L, Seoud M (2013). Burden of human papillomavirus infections and related diseases in the extended middle east and North Africa Region. Vaccine, 31:G32-G44.
15. Thomsen LT (2014). High-Risk and Low-Risk Human Papillomavirus and the Absolute Risk of Cervical Intraepithelial Neoplasia. Obstetr Gynecol, 123.
16. DeCew AE, Hadler JL, Daley AM, Niccolai L (2013). The prevalence of HPV associated cervical intraepithelial neoplasia in women under age 21: who will be missed under the new cervical cancer screening guidelines? J Pediatr Adolesc Gynecol, 26:346-9.
17. No authors listed (2013). [HPV and cervical cancer]. J Midwifery Womens Health, 58:245-6.
18. Halec G, Schmitt M, Dondog B et al. (2013). Biological activity of probable/possible highrisk human papillomavirus types in cervical cancer. Int J Cancer, 132:63-71.
19. Tzenov YR, Andrews PG, Voisey K, Popadiuk P, Xiong J, Popadiuk C, Kao KR (2013). Human papilloma virus (HPV) E7-mediated attenuation of retinoblastoma (Rb) induces hPygopus2 expression via Elf-1 in cervical cancer. Mol Cancer Res, 11:19-30.
20. Amaro-Filho SM, Golub JE, Nuovo GJ et al. (2013). A comparative analysis of clinical and molecular factors with the stage of cervical cancer in a Brazilian cohort. PLoS One, 8:e57810.
21. Katki HA, Schiffman M, Castle PE et al. (2013). Five-year risks of CIN 3+ and cervical cancer among women with HPV testing of ASC-US Pap results. J Low Genit Tract Dis, 17:S36-42.
22. Jacobs MV, Walboomers JM, Snijders PJ, Voorhorst FJ, Verheijen RH, Fransen-Daalmeijer N, Meijer CJ (2000). Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the agerelated patterns for high-risk and low-risk types. Int J Cancer, 87:221-7.
23. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ (2002). GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol, 40:779-87.
24. Abreu AL, Souza RP, Gimenes F, Consolaro ME (2012). A review of methods for detect human Papillomavirus infection. Virol J, 9:262.
25. Shahsiah R, Khademalhosseini M, Mehrdad N, Ramezani F, Nadji SA (2011). Human papillomavirus genotypes in Iranian patients with cervical cancer. Pathol Res Pract, 207:754-7.
26. Ghaffari SR, Sabokbar T, Mollahajian H, Dastan J, Ramezanzadeh F, Ensani F, Yarandi F, Mousavi-Jarrahi A, Mohagheghi MA, Moradi A (2006). Prevalence of human papillomavirus genotypes in women with normal and abnormal cervical cytology in Iran. Asian Pac J Cancer Prev, 7:529-32.
27. Haghshenas M, Golini-Moghaddam T, Rafiei A, Emadeian O, Shykhpour A, Ashrafi GH (2013). Prevalence and type distribution of high-risk human papillomavirus in patients with cervical cancer: a population-based study. Infect Agent Cancer, 8:20.
28. Farjadian S, Asadi E, Doroudchi M, Dehaghani AS, Tabei SZ, Kumar VP, Ghaderi A (2003). High risk HPV types in southern Iranian patients with cervical cancer. Pathol Oncol Res, 9:121-5.
29. Esmaeili M, Bonyadi M, Dastranj A, Alizadeh M, Melli MS, Shobeiri MJ (2008). HPV typing in women with cervical precancerous and cancerous lesions in northwestern Iran. Gynecol Obstet Invest, 66:68-72.
30. Abd El-Azim S, Lotfy M, Omr A (2011). Detection of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cancer patients: Sharkia Governorate, Egypt. Clin Lab, 57:363-71.
31. Al-Badawi IA, Al-Suwaine A, Al-Aker M, Asaad L, Alaidan A, Tulbah A, Fe Bohol M, Munkarah AR (2011). Detection and genotyping of human papilloma virus in cervical cancer specimens from Saudi patients. Int J Gynecol Cancer, 21:907-10.
32. Alsbeih G, Al-Harbi N, El-Sebaie M, Al-Badawi I (2013). HPV prevalence and genetic predisposition to cervical cancer in Saudi Arabia. Infect Agent Cancer, 8:15.
33. De Vuyst H, Clifford G, Li N, Franceschi S (2009). HPV infection in Europe. Eur J Cancer, 45:2632-9.
34. Raza SA, Franceschi S, Pallardy S, Malik FR, Avan BI, Zafar A, Ali SH, Pervez S, Serajuddaula S, Snijders PJ, van Kemenade FJ, Meijer CJ, Shershah S, Clifford GM (2010). Human papillomavirus infection in women with and without cervical cancer in Karachi, Pakistan. Br J Cancer, 102:1657-60.
35. Ciapponi A, Bardach A, Glujovsky D, Gibbons L, Picconi MA (2011). Type-specific HPV prevalence in cervical cancer and high-grade lesions in Latin America and the Caribbean: systematic review and meta-analysis. PLoS One, 6:e25493.
36. Kirschner B, Junge J, Holl K, Rosenlund M, Collas de Souza S, Quint W, Molijn A, Jenkins D, Schledermann D (2013). HPV genotypes in invasive cervical cancer in Danish women. Acta Obstet Gynecol Scand, 92:1023-31.
37. Asadi-Amoli F, Heidari AB, Jahanzad I, Jabbarvand M (2011). Detection of human papillomavirus in squamous cell carcinoma of conjunctiva by nested PCR: a case control study in Iran. Acta Med Iran, 49:707-14.
38. Mortazavi S, Zali M, Raoufi M, Nadji M, Kowsarian P, Nowroozi A (2002). The Prevalence of Human Papillomavirus in Cervical Cancer in Iran. Asian Pac J Cancer Prev, 3:69-72.